Sofinnova-Investments

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "AXSM",
  "EWTX",
  "INSM",
  "JAZZ",
  "ACAD",
  "PTCT",
  "ALNY",
  "ANAB",
  "AVBP",
  "RCUS",
  "GPCR",
  "IMTX",
  "SVRA",
  "RAPP",
  "PHVS",
  "REPL",
  "SNDX",
  "GILD",
  "BIOA",
  "BOLT",
  "ESTA",
  "SRRK",
  "ISRG",
  "INBX",
  null,
  "NXTC",
  "MDT",
  "IDYA",
  "INCY",
  "SYK",
  "RNA",
  null,
  "PRAX",
  "RYTM",
  "SLNO",
  "SUPN",
  "QURE",
  "COGT",
  "DYN",
  "SRPT",
  "PEN",
  "NTRA",
  "ROIV",
  "ERAS",
  "ELVN",
  "IKNA",
  "IMNM",
  "INZY",
  "KURA",
  "VIR",
  "YMAB",
  "VERA",
  "BPMC",
  "BMY",
  "BBIO",
  "DHR",
  "DXCM",
  "IRON",
  "QQQ",
  "IWM",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 62
Total Value: 1486841997
Accession Number: 0001104659-25-049266
Form Type: 13F-HR
CIK: sofinnova-investments
Manager Name: Sofinnova-Investments

Data Enrichment

97% identified

60 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

62 positions • $1.5B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 4

Sort by:

Blueprint Medicines Corp

BPMC|09627Y109

Shares:261.0K

Value:$23.1M

% of Portfolio:1.6% ($23.1M/$1.5B)

BRISTOL MYERS SQUIBB CO

BMY|110122108

Shares:371.5K

Value:$22.7M

% of Portfolio:1.5% ($22.7M/$1.5B)

INCYTE CORP

INCY|45337C102

Shares:357.8K

Value:$21.7M

% of Portfolio:1.5% ($21.7M/$1.5B)

ANAPTYSBIO, INC

ANAB|032724106

Shares:1.2M

Value:$21.6M

% of Portfolio:1.5% ($21.6M/$1.5B)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:327.6K

Value:$20.9M

% of Portfolio:1.4% ($20.9M/$1.5B)

Akero Therapeutics, Inc.

AKRO|00973Y108

Shares:510.0K

Value:$20.6M

% of Portfolio:1.4% ($20.6M/$1.5B)

Axsome Therapeutics, Inc.

AXSM|05464T104

Shares:175.3K

Value:$20.4M

% of Portfolio:1.4% ($20.4M/$1.5B)

Rapport Therapeutics, Inc.

RAPP|75383L102

Shares:2.0M

Value:$20.0M

% of Portfolio:1.3% ($20.0M/$1.5B)

SUPERNUS PHARMACEUTICALS, INC.

SUPN|868459108

Shares:520.7K

Value:$17.1M

% of Portfolio:1.1% ($17.1M/$1.5B)

Savara Inc

SVRA|805111101

Shares:5.5M

Value:$15.2M

% of Portfolio:1.0% ($15.2M/$1.5B)

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:2.2M

Value:$13.1M

% of Portfolio:0.9% ($13.1M/$1.5B)

Roivant Sciences Ltd.

ROIV|G76279101

Shares:1.3M

Value:$12.9M

% of Portfolio:0.9% ($12.9M/$1.5B)

DANAHER CORP /DE/

DHR|235851102

Shares:58.6K

Value:$12.0M

% of Portfolio:0.8% ($12.0M/$1.5B)

Penumbra Inc

PEN|70975L107

Shares:42.9K

Value:$11.5M

% of Portfolio:0.8% ($11.5M/$1.5B)

Avidity Biosciences, Inc.

RNA|05370A108

Shares:379.9K

Value:$11.2M

% of Portfolio:0.8% ($11.2M/$1.5B)

Inhibrx Biosciences, Inc.

INBX|45720N103

Shares:697.9K

Value:$9.8M

% of Portfolio:0.7% ($9.8M/$1.5B)

Y-mAbs Therapeutics, Inc.

YMAB|984241109

Shares:2.2M

Value:$9.7M

% of Portfolio:0.7% ($9.7M/$1.5B)

008064107

Shares:3.8M

Value:$9.4M

% of Portfolio:0.6% ($9.4M/$1.5B)

Pharvaris N.V.

PHVS|N69605108

Shares:593.4K

Value:$9.3M

% of Portfolio:0.6% ($9.3M/$1.5B)

BioAge Labs, Inc.

BIOA|09077V100

Shares:2.3M

Value:$8.7M

% of Portfolio:0.6% ($8.7M/$1.5B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Blueprint Medicines Corp(BPMCcusip09627Y109)	261.0K	QoQ NEW(+261.0K) YoY NEW(+261.0K)	All Managers (Combined)	$23.1M	1.6% ($23.1M/$1.5B)	QoQ NEW(+$23.1M) YoY NEW(+$23.1M)
BRISTOL MYERS SQUIBB CO(BMYcusip110122108)	371.5K	QoQ NEW(+371.5K) YoY NEW(+371.5K)	All Managers (Combined)	$22.7M	1.5% ($22.7M/$1.5B)	QoQ NEW(+$22.7M) YoY NEW(+$22.7M)
INCYTE CORP(INCYcusip45337C102)	357.8K	QoQ -31.75% (-166.5K) YoY -73.04% (-969.4K)	All Managers (Combined)	$21.7M	1.5% ($21.7M/$1.5B)	QoQ -40.17% (-$14.5M) YoY -71.34% (-$53.9M)
ANAPTYSBIO, INC(ANABcusip032724106)	1.2M	QoQ +772.68% (+1.0M) YoY NEW(+1.2M)	All Managers (Combined)	$21.6M	1.5% ($21.6M/$1.5B)	QoQ +1125.31% (+$19.8M) YoY NEW(+$21.6M)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	327.6K	QoQ -23.59% (-101.2K) YoY +44.01% (-100.1K)	All Managers (Combined)	$20.9M	1.4% ($20.9M/$1.5B)	QoQ -59.89% (-$31.2M) YoY -29.00% (-$8.5M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	510.0K	QoQ NEW(+510.0K) YoY NEW(+510.0K)	All Managers (Combined)	$20.6M	1.4% ($20.6M/$1.5B)	QoQ NEW(+$20.6M) YoY NEW(+$20.6M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	175.3K	QoQ -64.34% (-316.4K) YoY NEW(+175.3K)	All Managers (Combined)	$20.4M	1.4% ($20.4M/$1.5B)	QoQ -50.85% (-$21.2M) YoY NEW(+$20.4M)
Rapport Therapeutics, Inc.(RAPPcusip75383L102)	2.0M	QoQ 0.00% (-0) YoY NEW(+2.0M)	All Managers (Combined)	$20.0M	1.3% ($20.0M/$1.5B)	QoQ -43.46% (-$15.4M) YoY NEW(+$20.0M)
SUPERNUS PHARMACEUTICALS, INC.(SUPNcusip868459108)	520.7K	QoQ NEW(+520.7K) YoY NEW(+520.7K)	All Managers (Combined)	$17.1M	1.1% ($17.1M/$1.5B)	QoQ NEW(+$17.1M) YoY NEW(+$17.1M)
Savara Inc(SVRAcusip805111101)	5.5M	QoQ +0.18% (-10.4K) YoY +133.53% (+3.1M)	All Managers (Combined)	$15.2M	1.0% ($15.2M/$1.5B)	QoQ -9.60% (-$1.6M) YoY +29.89% (+$3.5M)
Cogent Biosciences, Inc.(COGTcusip19240Q201)	2.2M	QoQ +165.09% (+1.4M) YoY -9.10% (-218.7K)	All Managers (Combined)	$13.1M	0.9% ($13.1M/$1.5B)	QoQ +103.57% (+$6.7M) YoY -18.98% (-$3.1M)
Roivant Sciences Ltd.(ROIVcusipG76279101)	1.3M	QoQ NEW(+1.3M) YoY +27.73% (+277.8K)	All Managers (Combined)	$12.9M	0.9% ($12.9M/$1.5B)	QoQ NEW(+$12.9M) YoY +22.27% (+$2.4M)
DANAHER CORP /DE/(DHRcusip235851102)	58.6K	QoQ +486.06% (+48.6K) YoY NEW(+58.6K)	All Managers (Combined)	$12.0M	0.8% ($12.0M/$1.5B)	QoQ +423.38% (+$9.7M) YoY NEW(+$12.0M)
Penumbra Inc(PENcusip70975L107)	42.9K	QoQ NEW(+42.9K) YoY NEW(+42.9K)	All Managers (Combined)	$11.5M	0.8% ($11.5M/$1.5B)	QoQ NEW(+$11.5M) YoY NEW(+$11.5M)
Avidity Biosciences, Inc.(RNAcusip05370A108)	379.9K	QoQ +2655.31% (+366.1K) YoY NEW(+379.9K)	All Managers (Combined)	$11.2M	0.8% ($11.2M/$1.5B)	QoQ +2697.01% (+$10.8M) YoY NEW(+$11.2M)
Inhibrx Biosciences, Inc.(INBXcusip45720N103)	697.9K	QoQ +32.38% (+170.7K) YoY NEW(+697.9K)	All Managers (Combined)	$9.8M	0.7% ($9.8M/$1.5B)	QoQ +20.26% (+$1.6M) YoY NEW(+$9.8M)
Y-mAbs Therapeutics, Inc.(YMABcusip984241109)	2.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.7M	0.7% ($9.7M/$1.5B)	QoQ -43.42% (-$7.5M) YoY -72.75% (-$26.0M)
(cusip008064107)✕	3.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.4M	0.6% ($9.4M/$1.5B)	QoQ -5.28% (-$526.2K) YoY -91.51% (-$101.7M)
Pharvaris N.V.(PHVScusipN69605108)	593.4K	QoQ +5.82% (-32.7K) YoY +1.49% (-8.7K)	All Managers (Combined)	$9.3M	0.6% ($9.3M/$1.5B)	QoQ -13.32% (-$1.4M) YoY -31.04% (-$4.2M)
BioAge Labs, Inc.(BIOAcusip09077V100)	2.3M	QoQ 0.00% (-0) YoY NEW(+2.3M)	All Managers (Combined)	$8.7M	0.6% ($8.7M/$1.5B)	QoQ -35.06% (-$4.7M) YoY NEW(+$8.7M)